Descrizione business
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Guillaume Daniellot |
| Consiglio di amministrazione |
| Dr. Peter Hackel, Camila Finzi, Wolfgang Becker, Jason Forbes , Holger Haderer, Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Rahma Samow, Matthias Schupp, Dr Christian Ullrich |
| Consiglio di sorveglianza |
| Petra Rumpf, Dr. Beat Lüthi, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol, Regula Wallimann |
Dati aziendali
| Name: |
Straumann Holding AG |
| Indirizzo: |
Peter Merian-Weg 12,CH-4052 Basel |
| Telefono: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| E-mail: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
57.90% |
| Data dell'IPO: |
01/01/1998 |
